Nonstandard Antibodies as Prognostic Markers in Autoimmune Hepatitis

References

• Czaja, A.J. and Freese, D.K. (2002) "Diagnosis and treatment of autoimmune hepatitis", Hepatology 36, 479–497.
   PubMed Web of Science ®Google Scholar
• Alvarez, F., Berg, RA., Bianchi, F.B., Bianchi, L., Burroughs, AK., Cancado, EL., et al. (1999) "International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis", J. Hepatol. 31, 929–938.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J. (1995) "Autoantibodies", Bailliere's Clin. Gastro-enterol. 9, 723–744.
   PubMedGoogle Scholar
• Gregorio, G.V., Portmann, B., Reid, F., Donaldson, RT., Doherty, D.G., McCartney, M., et al. (1997) "Autoimmune hepatitis in childhood. A 20 year survey", Hepatology 25,541–547.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J. (1999) "Behavior and significance of autoantibodies in type 1 autoimmune hepatitis", J. Hepatol. 30, 394–401.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J. and Homberger, RA. (2001) "Autoantibodies in liver disease", Gastroenterology 120, 239–249.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J. and Norman, G.L. (2003) "Autoantibodies in the diagnosis and management of liver disease", J. Clin. Gastroenterol. 37, 315–329.
   PubMed Web of Science ®Google Scholar
• Kanzler, S., Weidemann, C., Gerken, G., Lohr, H.F., Galle, P.R., Meyer zum Buschenfelde, K.H., et al. (1999) "Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis", J. Hepatol. 31, 635–640.
   PubMed Web of Science ®Google Scholar
• Baeres, M., Herkel, J., Czaja, A.J., Wies, I., Kanzler, S., Cancado, E.L.R., et al. (2002) "Establishment of standardized SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics", Gut 51, 259–264.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Donaldson, RT. and Lohse, A.W. (2002) "Antibodies to soluble liver antigen/liver pancreas and HLA risk factors in type 1 autoimmune hepatitis", Am. J. Gastroenterol. 97, 413–419.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Shums, Z. and Norman, G.L. (2002) "Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis", Autoimmunity 35, 475–483.
   PubMed Web of Science ®Google Scholar
• Ma, Y., Okamoto, M., Thomas, M.G., Bogdanos, D.P., Lopes, A.R., Portmann, B., et al. (2002) "Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease", Hepatology 35, 658–664.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Cassani, F., Cataleta, M., Valentini, P. and Bianchi, F.B. (1996) "Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis", Hepatology 24, 1068–1073.
   PubMed Web of Science ®Google Scholar
• Czaja, AL, Shums, Z., Binder, W.L., Lewis, S.J., Nelson, V.J. and Norman, G.L. (2003) "Frequency and significance of antibodies to chromatin in autoimmune hepatitis", Dig. Dis. Sci. 48, 1658–1664. Martini, E., Abuaf, N., Cavalli, F., Durand, V., Johanet, C. and Homberg, J.-C. (1988) "Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2", Hepatology 8, 1662–1666.
   Google Scholar
• Abuaf, N., Johanet, C., Chretien, P., Martini, E., Soutier, E., Laperche, S., et al. (1992) "Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis", Hepatology 16, 892–898.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Carpenter, H.A. and Manns, M.P. (1993) "Antibodies to soluble liver antigen, P4501M6, and mitochondrial complexes in chronic hepatitis", Gastroenterology 105, 1522–1528.
   PubMedGoogle Scholar
• Li, L., Chen, M., Huang, D.Y. and Nishioka, M. (2000) "Frequency and significance of antibodies to chromatin in autoimmune hepatitis type 1", J. Gastroenterol. Hepatol. 15, 1176–1782.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Manns, M.P. and Homburger, HA. (1992) "Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis", Gastroenterology 103, 1290–1295.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Davis, G.L., Ludwig, J., Baggenstoss, A.H. and Taswell, H.F. (1983) "Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology", Gastroenterology 85, 713–717.
   PubMedGoogle Scholar
• Czaja, A.J. (2002) "Treatment of autoimmune hepatitis", Semin. Liver Dis. 22, 365–377.
   PubMed Web of Science ®Google Scholar
• Summerskill, W.H.J., Korman, M.G., Ammon, H.V. and Baggenstoss, A.H. (1975) "Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared", Gut 16, 876–883.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Menon, K.V.N. and Carpenter, H.A. (2002) "Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis", Hepatology 35, 890-897. DiMagno, ER, Corle, D., O'Brien, IF., Masnyk, U., Go, V.L.W. and Aamodt, R. (1989) "Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum", Mayo UM. Proc. 64, 1226–1234.
   Google Scholar
• Wies, I., Brunner, S., Henninger, J., Herkel, J., Meyer zum Buschenfelde, K.H. and Lohse, A.W. (2000) "Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis", Lancet 355, 1510–1515.
   PubMed Web of Science ®Google Scholar
• Muratori, L., Sztul, E., Muratori, P., Gao, IS., Ripalti, A., Ponti, C., et al. (2001) "Distinct epitopes on formiminotransferase cyclode-aminase induce autoimmune liver cytosol antibody type 1", Hepatology 34, 494–501.
   PubMed Web of Science ®Google Scholar
• Mohan, C.H., Adams, S., Stanik, V. and Datta, S.K. (1993) "Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus", J. Exp. Med. 177, 1367-1381. Amoura, Z., Koutouzov, S. and Piette, J.-C. (2000) "The role of nucleosomes in lupus", Curr. Opin. Rheumatol. 12, 369-373. Costa, M., Rodriques-Sanchez, IL., Czaja, A.J. and Gelpi, C. (2000) "Isolation and characterization of cDNA encoding the antigenic protein of the human tRNA(s")see complex recognized by autoantibodies from patients with type 1 autoimmune hepatitis", UM. Exp. Immunol. 121, 364–374.
   Google Scholar
• Czaja, A.J., Rakela, J. and Ludwig, J. (1988) "Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis", Gastroenterology 95, 448–453.
   PubMed Web of Science ®Google Scholar
• Donaldson, RT., Doherty, D.G., Hayllar, K.M., McFarlane, LG., Johnson, P.J. and Williams, R. (1991) "Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors", Hepatology 13, 701–706.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Carpenter, H.A., Santrach, P.J. and Moore, S.B. (1993) "Significance of HLA DR4 in type 1 autoimmune hepatitis", Gastroenterology 105, 1502–1507.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J., Strettell, M.D.J., Thomson, L.J., Santrach, P.J., Moore, S.B., Donaldson, P.T., et al. (1997) "Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis", Hepatology 25, 317–323.
   PubMed Web of Science ®Google Scholar
• Whitacre, C.C., Reingold, S.C. and O'Looney, RA. (1999) "A gender gap in autoimmunity", Science 283, 1277–1278.
   PubMed Web of Science ®Google Scholar
• Czaja, A.J. and Donaldson, P.T. (2002) "Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis", Am. J. Gastroenterol. 97, 2051–2057.
   PubMed Web of Science ®Google Scholar